Immunology and Genetics Journal

Safeguarding Public Health in Conflict Zones: A Global Responsibility

2025-11-06T09:02:09+00:00

The Article Abstract is not available.

Unraveling the M1R Protein of Monkeypox Virus: An Integrated Struc- tural Bioinformatics, Immunological Profiling, and Molecular Dynam- ics Simulation Approach

2025-11-05T11:05:05+00:00

Background: Monkeypox virus (MPXV) is a zoonotic pathogen that affects both humans and animals, posing a significant publichealth concern due to its emergence and circulation. The structural dynamics and features of several MPXV proteins, includingM1R, are not completely studied.

Methods: This experiment focuses on the prediction and analysis of the secondary and tertiary constructs for the M1R protein.Briefly, its amino acid sequence was collected from the UniProt database. A wide range of in silico approaches were employed,including ProtParam, SOPMA, PSIPRED, CD Search, GalaxyTMB, Robetta, I-TASSER, and GROMACS, in order to explore thephysicochemical properties, structural features, and functional insights of the M1R protein. The tertiary structure models wereevaluated to detect the most reliable solution, which was then used for Immunoinformatics analyses such as MHC I/II and B-cellepitope prediction using the IEDB and Ellipro tools, respectively. Epitopes from the M1R protein were evaluated based on anti-genicity, affinity of binding, along solubility. Furthermore, active sites were forecast by the CASTp v3.0 tool.

Results: Physicochemical calculations indicate that M1R had favorable thermostability and hydrophilic features. Structural anal-yses suggested that M1R is a lipid membrane protein component of DNA viruses, suggesting it as a robust antigenic target. Im-munogenicity analyses indicated it as a potentially suitable target for immunogenic protein design. As well, molecular dynamicssimulations (MDS) were carried out for 100-ns using an all-atom forcefield. Analysis of various molecular dynamics parametersof M1R throughout the MDS trajectory, including RMSD, RMSF, radius of gyration (Rg), and solvent accessible surface area(SASA), indicated good stability of the M1R and unveiled important molecular dynamics characteristics such as the flexibility ofcertain protein regions. Multiple epitopes were detected in our experiment, with 12 B-cell epitopes identified using the Robettamodel and 6 B-cell epitopes predicted by the Galaxy model, alongside 3 MHC-I and 3 MHC-II epitopes, which scored favorably.

Conclusion: The results of the present computational analysis provide clues to unleash the potential of M1R as an immunother apy target for the development of antiviral solutions against MPXV in the future

Hematological Parameters in Patients with Allergic Rhinosinusitis Combined with Chronic Allergic Otitis Media

2025-11-05T11:05:04+00:00

Background: Allergic rhinosinusitis (ARS) and chronic allergic otitis media are common manifestations of upper airway allergic inflammation. Despite advances in understanding the immunopathogenesis of these conditions, hematological markers reflecting systemic immune activation remain underexplored, particu- larly in combined presentations. To evaluate hematological parameters, with emphasis on leukocyte sub- populations and the eosinophil-lymphocytic index, in patients with allergic rhinosinusitis combined with chronic allergic otitis media compared to non-allergic chronic otitis media.

Methods: Archival records of 60 adult patients (33 males, 27 females; mean age 41.2 years) from the Otorhinolaryngology Department of the National Medical Center “Shifobakhsh,” Republic of Tatarstan, were analyzed. Group I (n=30) included ARS with CAOM, and Group II (n=30) included non-allergic COM. Complete blood count (CBC) with leukocyte differential and ELI were assessed and compared de- scriptively. Correlation analysis between leukocyte subpopulations was also performed.

Results: Mean total leukocyte count in allergic patients was near the upper normal range (8.9×10⁹/L). Leukocytosis was observed in 16.7% of allergic versus 40% of non-allergic cases. Peripheral eosinophilia (>5%) was observed in 63.3% of patients with allergies, with a mean eosinophil count of 5.8%. Relative lymphocytosis occurred in 40% of allergic and 16.7% of non-allergic patients, while absolute lymphocyte counts were lower in the allergic group. ELI was increased in 43.3% of patients with allergies. Correlation analysis revealed strong relationships (η>0.90) between neutrophils, eosinophils, and monocytes in both groups, indicating coordinated immune responses.

Conclusion: Peripheral eosinophilia and elevated ELI serve as indirect hematological markers of systemic allergic sensitization in ARS with CAOM. These findings support using simple blood parameters as adjunc- tive indicators of allergic inflammation when specialized allergy testing is unavailable.

Design of a Trivalent DC-inducing mRNA Vaccine Against Monkeypox, Cowpox, and Vaccinia Viruses: A Computational Approach

2025-11-05T11:05:03+00:00

Background: Monkeypox virus (MPXV) is a novel virus that has been disseminated around the globe and caused human disease. Over 86 thousand infection cases have been reported, which has concerned the World Health Organization (WHO). Given the challenges faced due to the spread of MPXV, an immune-mediating therapy to prevent infection by MPXV is invaluable to aid large-scale public health practices. In this field, the mRNA vaccine could be a sufficient way to control the virus's transmissibility around worldwide study; we used immunoinformatic approaches that aided the pathway to develop the novel mRNA vaccine.

Methods: In the first step, we gathered three key proteins (A35R, cell surface binding, and M1R) conserved in Cowpox as well as Vaccinia viruses for the design of vaccines and computed the potent immunogen epitopes that the engineered vaccines assemble with the fused finalized epitopes and Beta-defensin 3 adjuvant that is a major stimulation of dendritic cells (DCs), along with the PADRE and TAT sequences were added. The vaccine construct was modeled with Robetta tool and validated by PROCHECK, ERRAT, and Z-score. Physicochemical properties were also investigated and confirmed to be favorable. Disulfide engineering, immunological simulation, and molecular docking with TLR3 were performed. Finally, the construction of mRNA was designed in silico, the mRNA vaccine structure was predicted, and then the molecular dynamics simulation was performed to investigate the TLR3-vaccine complex. Results: The eighteen final epitopes were predicted. The engineered multi-epitope protein, entails 350 amino acids and had good structural quality, as quantified through an ERRAT value over 99%. Also, engineering of disulfide bond was performed in order to augment the construct stability of the MPXV vaccine. The Ramachandran analysis was utilized to further corroborate the fa- vorable φ (phi) and ψ (psi) angles, with the aminoacids localized to the highly favorable or permitted regions. The design of the mRNA construct was achieved by incorporating the 5’UTR, start codon, signal peptide, open reading frames, stop codon,3’UTR, and polyA. In addition, the immune simulation showed sustained immune response. Also, the molecular dynamic simulation (MDS) and energy analyses suggested that the vaccine-TLR3 complex binding was stable. Conclusion: An mRNA vaccine was designed to provoke a robust immune response against MPXV while offering immunopro- tection against Cowpox and Vaccinia. The present work analyzed the structure of a novel multi-epitope vaccine, which indicated it could be an effective option against MPXV infection. Future study is recommended to confirm the immunomodulatory role of the designed MPXV vaccine

Clinical and Immunological Correlates of Skin Prick Test Reactivity and Anaphylaxis During Allergen-Specific Immunotherapy in Children with Asthma and Allergic Rhinitis

2025-11-05T11:05:02+00:00

Background: Allergen-specific immunotherapy (AIT) is an effective treatment for allergic rhinitis and asthma, aiming to induce immune tolerance through repeated exposure to allergens. Although skin prick testing (SPT) is commonly used to identify sensitized individuals, its predictive value for systemic reactions during AIT, including anaphylaxis, remains uncertain. To investigate the correlation between the diameter of the wheal in SPT and the incidence of anaphylactic shock during subcutaneous immunotherapy in patients with allergic rhinitis and asthma.

Methods: This cross-sectional observational study included 255 pediatric patients aged 3–18 years with allergic rhinitis and/or asthma who underwent SPT at an allergy clinic in 2019. Patients with a positive SPT (wheal ≥3 mm) received subcutaneous AIT using standard allergen extracts for a period of three years. All patients were monitored for 20 minutes post-injection for adverse reactions. The size of SPT wheals was compared between patients who experienced anaphylactic reactions and those who did not.

Results: The mean age of patients was 10.2 ± 3.7 years; 68.2% were male. Of the 255 patients, 2.4% (n=6) experienced anaphylactic shock—two of grade I and four of grade II severity. Anaphylaxis occurred only in patients with allergic rhinitis or rhinitis combined with asthma; no cases were observed in patients with asthma alone (p=0.04). The average SPT wheal sizes for common allergens, particularly Dermatophagoides pteronyssinus, were slightly larger in patients with anaphylaxis, but the differences were not statistically significant (p>0.05).

Conclusion: There was no significant correlation between SPT wheal size and the risk or severity of anaphylaxis during AIT. However, allergic rhinitis appeared to be more associated with systemic reactions than asthma. These findings suggest that the magnitude of local skin reactivity may not reliably predict systemic hypersensitivity outcomes during immunotherapy. Further studies with larger sample sizes and more advanced immunological profiling are recommended.

Clinical Relevance of High HHV-6B Viral Load in Immunocompromised Host

2025-11-05T11:05:00+00:00

The peculiarity of the chromosomally integrated form of human herpesvirus type 6 (ciHHV-6) is its wide distribution (up to 1% of the population), the possibility of transmission by inheritance, the problem of diagnosis, including issues of differential diagnosis with the acute form of HHV-6 infection, which, in turn, makes it difficult to resolve the problem of the therapy necessity. In addition, activation of ciHHV-6 is possible sometimes with acute infection clinical symptoms and the need for antiviral therapy, especially in patients after bone marrow transplantation and chemotherapy. We report a 10-years-old girl after chias- mal-sellar germinoma surgery and subsequent chemotherapy with ciHHV-6B. The child was treated with ganciclovir. This did not significantly influence the reduction of the viral load HHV-6B DNA in serum and cerebrospinal fluid. No adverse effects of antiviral treatment were registered. It’s important to exclude ciH- HV-6 before the diagnosis of HHV-6 active disease is made, as this screening may prevent the unnecessary use of antivirals.

Hematological Complications in Familial Mediterranean Fever: A Case Report and Literature Review

2025-11-05T11:04:59+00:00

Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease caused by mutations in the MEFV gene. These patients typically present with lymphocytosis and thrombocytosis during periods of inflammation; however, some patients may manifest leukopenia along with other symptoms. Demographic data, medical history, laboratory data, and genetic findings of the cases were collected by reviewing clinical records of the patient. Whole-genome sequencing test revealed a mutation in MEFV gene. A systematic searched was conducted in four databases: PubMed, Web of Science, Scopus, and PerQuest, using keywords related to blood abnormalities in FMF disease. A mutation in the MEFV gene was confirmed in a 29-year- old patient with FMF. He experienced periodic and regular decreases in the number of neutrophils, lym- phocytes, and platelets during periods of inflammation. Our literature review revealed neutropenia (17.6%), lymphopenia (8.8%), thrombocytopenia (11.8%), leukopenia (61.8%), and anemia (20.6%) are the frequent most common hematologic complications. Genetic analysis in 28 patients revealed M694V as the most prevalent mutation (57.1%), followed by E148Q (21.4%), M680I (10.7%), and others. Reporting this case and others highlights that hematological manifestations in FMF can be observed periodic and simultaneous decreases in neutrophils, lymphocytes, and platelet counts can in patients with FMF